Clinical Trials Sponsored by ORION Sante

Total 3259 results

Orion Corporation, Orion Pharma

Completed

Peroral Levosimendan in Chronic Heart Failure

Heart Diseases | Chronic Heart Failure

Finland
Orion Corporation, Orion Pharma

Terminated

Dexmedetomidine for Continuous Sedation

Conscious Sedation

Finland, Switzerland
Air Liquide Santé International
ORION Clinical Services

Completed

Hyperalgesia and Pain

Hyperalgesia

Germany
Bayer
Orion Corporation, Orion Pharma

Completed

Efficacy and Safety Study of Darolutamide (ODM-201) in Men With High-risk Non-metastatic Castration-resistant Prostate Cancer (ARAMIS)

Prostate Cancer Non-Metastatic | Castration-Resistant

Belgium, France, Poland, Spain, Canada, United States, Estonia, Portugal, Taiwan, Japan, Russian Federation, Finland, Germany, Austria, Czechia, Hungary, Australia, Brazil, South Africa, Latvia, Italy, United Kingdom, Turkey, Serbia, Ro... and more
Bayer
Orion Corporation, Orion Pharma

Completed

Effect of Hepatic and Renal Impairment on the Pharmacokinetics, Safety and Tolerability of BAY1841788 (ODM-201)

Hepatic Insufficiency | Renal Insufficiency | Pharmacokinetics

Germany
Bayer
Orion Corporation, Orion Pharma

Completed

Drug-drug Interaction (DDI) Study to Assess ODM-201 as a Victim of CYP3A4 Inhibition or Induction

Biological Availability

Germany
Abbott
Orion Corporation, Orion Pharma

Completed

Survival of Patients With Acute Heart Failure in Need of Intravenous Inotropic Support: a Multicentre, Parallel-Group, Randomised, Double-Blind, Double-Dummy Study of Levosimendan Versus Dobutamine in Patients With Acute Heart Failure.

Acute Heart Failure

United States
Orion Corporation, Orion Pharma

Recruiting

Effect of Electronic Monitoring and Feedback on Adherence to Easyhaler Controller Medication in Patients With Asthma (eMOFEE)

Asthma

Germany
Orion Corporation, Orion Pharma

Completed

Digital Therapeutics (DTx) for Pain: Pilot Study of a Virtual Reality Software for Chronic Pain (VIRPI)

Chronic Low Back Pain

Finland
Orion Corporation, Orion Pharma

Completed

Efficacy and Safety of Remo-Wax® Oil (RWO) in Subjects With Isolated Itching of the External Ear Canal (Remo_Itch)

Itching

Lithuania
Orion Corporation, Orion Pharma

Completed

Dose-finding Pharmacokinetic Study in Healthy Males (COMDOS1)

Healthy Volunteers

Germany
Orion Corporation, Orion Pharma

Completed

Safety and Efficacy of ORM-12741 in Patients With Alzheimer's Disease (ALPO)

Alzheimer's Disease

Finland
Orion Corporation, Orion Pharma

Completed

Salmeterol/Fluticasone Easyhaler in the Treatment of Asthma and COPD (SUNNY)

Chronic Obstructive Pulmonary Disease | Asthma

Germany
Orion Corporation, Orion Pharma

Completed

Safety and Pharmacokinetics of ODM-204 in Patients With Metastatic Castration-Resistant Prostate Cancer (DUALIDES)

Prostate Cancer

Finland, France, United Kingdom, Latvia
Orion Corporation, Orion Pharma

Completed

ODM-207 in Patients With Advance Solid Tumours (BETIDES)

Solid Tumors

Finland
Orion Corporation, Orion Pharma

Completed

Effect of Charcoal on Gastrointestinal Absorption of Tiotropium (TIOBLOCK)

Healthy Volunteer Study

Finland
Orion Corporation, Orion Pharma

Terminated

Non-interventional Comparison of Sedatives on Weaning From Mechanical Ventilation in Intensive Care Patients (NICEWEAN)

Critical Illness

Sweden
Orion Corporation, Orion Pharma

Completed

Safety, Tolerability and Efficacy of DEXDOR in Pediatric Patients in ICU (Pedrux)

ICU Sedation

Russian Federation
Orion Corporation, Orion Pharma

Completed

Pharmacokinetic Study Comparing Tiotropium Easyhaler and Spiriva Handihaler

Healthy Subjects

Finland
Orion Corporation, Orion Pharma

Completed

Pharmacokinetic Study Comparing Salmeterol/Fluticasone Easyhaler and Seretide Diskus

Asthma

Finland
Orion Corporation, Orion Pharma

Completed

Safety, Tolerability,Pharmacokinetics and Pharmacodynamics of ODM-106 in Healthy Volunteers (FIMPAM)

Healthy Volunteer Study

Germany
Orion Corporation, Orion Pharma

Completed

Pharmacokinetic Study in Healthy Volunteers (NOCOFPK2)

Parkinson's Disease

Finland
Orion Corporation, Orion Pharma

Completed

Pharmacokinetic Study Comparing Salmeterol/Fluticasone Easyhaler Products and Seretide Diskus

Asthma

Finland
Orion Corporation, Orion Pharma

Completed

Pharmacokinetic Study of Multiple Doses of ORM-12741 (Nebula PK 2)

Healthy

Finland
Orion Corporation, Orion Pharma

Completed

Prospective Multicentre Non-interventional Study of VANTAS® for the Treatment of Patients With Advanced Prostate Cancer (Vantas)

Prostate Cancer

Sweden
Orion Corporation, Orion Pharma

Terminated

Efficacy of ORM-12741 for Prevention of Raynaud's Phenomenon (REINO)

Raynaud's Phenomenon

United Kingdom
Orion Corporation, Orion Pharma

Completed

Comparison of Salmeterol and Fluticasone Propionate Absorption From Salmeterol/Fluticasone Easyhaler and Seretide Diskus

Asthma

Finland
Orion Corporation, Orion Pharma

Completed

Pharmacokinetic Study on Budesonide/Formoterol Device-metered Dry Powder Inhalers (REFLI)

Asthma

Germany
Orion Corporation, Orion Pharma

Completed

Comparison of Absorption of Budesonide and Formoterol From Budesonide/Formoterol Easyhaler and Symbicort Turbuhaler

Asthma

Finland
Orion Corporation, Orion Pharma

Completed

Pharmacokinetic Study Comparing Budesonide/Formoterol Easyhaler and Symbicort Turbuhaler Forte (ADECO)

Asthma

Germany
Orion Corporation, Orion Pharma

Completed

Dexmedetomidine Versus Midazolam for Continuous Sedation in the Intensive Care Unit (ICU) (MIDEX)

Continuous Sedation in Initially Sedated Adults in ICU

Netherlands, Belgium, Estonia, Finland, France, Germany, Norway, Switzerland, United Kingdom
Orion Corporation, Orion Pharma

Completed

Inspiratory Flow Parameters of Easyhaler and Diskus Inhalers (SALIF) (SALIF)

Chronic Obstructive Pulmonary Disease | Asthma

Finland, Estonia
Orion Corporation, Orion Pharma

Completed

Comparison of Budesonide and Formoterol Absorption From Budesonide/Formoterol Easyhaler and Symbicort Turbuhaler

Asthma

Finland
Orion Corporation, Orion Pharma

Completed

Phase I Pharmacokinetic Study (BF-BLOCK) (BF-BLOCK)

Asthma

Finland
Orion Corporation, Orion Pharma

Completed

Inspiratory Flow Parameters and Handling of Easyhaler and Turbuhaler Inhalers (PIFECO)

Pulmonary Disease, Chronic Obstructive | Asthma

United Kingdom, Finland
Orion Corporation, Orion Pharma

Completed

Bioequivalence Study of Budesonide/Formoterol Easyhaler and Symbicort Turbohaler in Asthmatics (KINECO)

Asthma

United Kingdom
Orion Corporation, Orion Pharma

Completed

Safety and Tolerability Study With Single Ascending Doses of ORM-12741

Healthy

France
Orion Corporation, Orion Pharma

Completed

Effects of Oral Levosimendan on Ambulatory Electrocardiographic Variables (Electro)

Stroke | Transient Ischemic Attack

Finland, Germany, Hungary, Sweden
Orion Corporation, Orion Pharma

Completed

Suitability of 11C-ORM-13070 as a PET Tracer

Healthy

Finland
Orion Corporation, Orion Pharma

Completed

Effect of Moisturising Creams on Skin Moisture in Atopic Dermatitis

Dermatitis, Atopic

Finland
Orion Corporation, Orion Pharma

Completed

Early Phase I Microdosing Study of ORM-14540 and ORM-12741

Healthy

Finland
Orion Corporation, Orion Pharma

Completed

Stalevo in Early Wearing-Off Patients (SEWOP)

Idiopathic Parkinson's Disease

United Kingdom, Denmark, Ireland, Finland, Germany, Sweden
Orion Corporation, Orion Pharma

Completed

Excretion Balance and Metabolism After a Single Oral Dose of 14C-Labelled ORM-12741 (ALMAS)

Healthy Male Volunteers

Netherlands
Orion Corporation, Orion Pharma

Completed

Pharmacokinetic Study With Repeated Doses of Stalevo

Pharmacokinetics

Finland
Orion Corporation, Orion Pharma

Completed

Comtess® Versus Cabaseril® as Add-on to Levodopa in the Treatment of Parkinsonian Patients Suffering From Wearing- Off.

Parkinson's Disease

Germany
Orion Corporation, Orion Pharma

Completed

Levosimendan Pretreatment for Weaning Patients From Cardio-Pulmonary Bypass

Coronary Heart Disease

Finland
Bayer
Orion Corporation, Orion Pharma

Active, not recruiting

Darolutamide in Addition to ADT Versus ADT in Metastatic Hormone-sensitive Prostate Cancer (ARANOTE)

Prostatic Neoplasms

China, Russian Federation, Taiwan, Latvia, India, Australia, Brazil, Canada, Chile, Lithuania, New Zealand, Peru, South Africa, Spain, Ukraine
MEDA Pharma GmbH & Co. KG
ORION Sante

Completed

Imiquimod 5% Cream in the Treatment of External Genital or Perianal Warts in HIV+ Patients

Warts

Belgium, France
Orion Corporation, Orion Pharma
Aerocrine AB

Terminated

Optimization of Inhaled Corticosteroid Treatment in Adult Patients With Asthma Guided by Exhaled NO Measurement at Home (OCTAGEN)

Asthma

Sweden
Orion Corporation, Orion Pharma
Janssen Pharmaceuticals

Completed

Efficacy of ORM-12741 on Agitation/Aggression Symptoms in Alzheimer's Disease (Nebula)

Alzheimer's Disease

Finland

Clinical Trials Sponsored by ORION Sante

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Djibouti

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations